Fournier´s Gangrene Under Sodium-Glucose Cotransporter 2 Inhibitor Therapy as a Life-Threatening Adverse Event: A Case Report and Review of the Literature

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a relatively new class of oral antidiabetic drugs. The US FDA has recently published a new warning about the safety of SGLT2 inhibitor administration in type 2 diabetes mellitus patients. There is an emerging evidence of an increased risk for dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodler, Severin, Weig, Thomas, Finkenzeller, Christa, Stief, Christian, Staehler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825492/
https://www.ncbi.nlm.nih.gov/pubmed/31723537
http://dx.doi.org/10.7759/cureus.5778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825492/
https://www.ncbi.nlm.nih.gov/pubmed/31723537
http://dx.doi.org/10.7759/cureus.5778

Ejemplares similares